LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients

SUPPLEMENTARY FIGURES AND TABLES Supplementary
: Dasatinib inhibits viability of lung ADC cells expressing high levels of LYN. Inhibitory effects of dasatinib on cell viability were assessed by dose-response curves in A. low LYN-expressing cells (H23 and SK-LU-1) and B. high LYNexpressing cells (H358 and H1975) . IC50 values were calculated based on fits using sigmoidal curves (n = 3). Figure S2 : Specificity of the SRC antibody (32G6 clone) is confirmed by western blot analysis using siRNA. Knockdown of SRC by siRNAs was confirmed by western blot analysis in H1792 cells. NT, non-targeting. 
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